New device aims to seal brain blood vessel leaks in kids
NCT ID NCT03731000
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at how well the PHIL Embolic System works to treat a rare brain condition in children called dural arteriovenous fistulas (DAVFs), where blood vessels connect abnormally. About 15 children under 22 will receive the treatment, which uses a special material to block the faulty vessels. The goal is to see if it is safe and effective at stopping the abnormal blood flow.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTERIO-VENOUS FISTULA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Sinai Hospital
RECRUITINGNew York, New York, 10029, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive 15-year study launched to crack the code on rare brain-spine vessel disease
- New device aims to keep dialysis fistulas working longer
- Massive study explores safety of Office-Based blood vessel procedures
- Super-Strength balloon aims to keep dialysis lifelines open
- Tiny trial tests best way to create dialysis access